Dysregulation of oncogenes and tumor suppressors usually leads to changes in the expression level of HK2, which in turn affects the reprogramming of glucose metabolism and has an important impact on the survival and proliferation of cancer cells (Fig. 1). Here, HK2 is linked to cancer.